Yanling Xiao

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Dendritic Cells

Regulatory T Cells

High Throughput

Top Venues

Nature communications

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Xin Lei, Indu Khatri, Tom de Wit, Iris de Rink, Marja Nieuwland, Ron Kerkhoven, Hans van Eenennaam, Chong Sun, Abhishek Dinkarnath Garg, Jannie Borst, Yanling Xiao
CD4 + helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment. Nature communications 14 (1) (2023)
Xin Lei, Indu Khatri, Tom de Wit, Iris de Rink, Marja Nieuwland, Ron Kerkhoven, Hans van Eenennaam, Chong Sun, Abhishek Dinkarnath Garg, Jannie Borst, Yanling Xiao
CD4 + helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment. Nature communications 14 (1) (2023)
Xin Lei, Indu Khatri, Tom de Wit, Iris de Rink, Marja Nieuwland, Ron Kerkhoven, Hans van Eenennaam, Chong Sun, Abhishek Dinkarnath Garg, Jannie Borst, Yanling Xiao
CD4 + helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment. Nature communications 14 (1) (2023)
Xin Lei, Indu Khatri, Tom de Wit, Iris de Rink, Marja Nieuwland, Ron Kerkhoven, Hans van Eenennaam, Chong Sun, Abhishek Dinkarnath Garg, Jannie Borst, Yanling Xiao
CD4 + helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment. Nature communications 14 (1) (2023)
Xin Lei, Indu Khatri, Tom de Wit, Iris de Rink, Marja Nieuwland, Ron Kerkhoven, Hans van Eenennaam, Chong Sun, Abhishek Dinkarnath Garg, Jannie Borst, Yanling Xiao
CD4 + helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment. Nature communications 14 (1) (2023)
Jesper van Eck van der Sluijs, Diede van Ens, Soley Thordardottir, Denise Vodegel, Inge A T Hermens, Anniek B van der Waart, J H Frederik Falkenburg, Michel G D Kester, Iris de Rink, Mirjam H M Heemskerk, Jannie Borst, Nicolaas P M Schaap, Joop H Jansen, Yanling Xiao, Harry Dolstra, Willemijn Hobo
Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses. Cancer immunology, immunotherapy : CII 70 (11) (2021)